Le Lézard
Classified in: Health
Subjects: PDT, PET, ANW, MAT

ElleVet Academy Launches with Classes on Cannabinoid Veterinary Science, Offering Free RACE Approved CE Credits for Veterinary Professionals


ElleVet looks forward to filling the need for CBD education in veterinary schools.

PORTLAND, Maine, Feb. 15, 2024 /PRNewswire-PRWeb/ -- ElleVet Sciences, the leading authority on cannabinoid veterinary science, proudly announces the launch of ElleVet Academy (ellevetacademy.com), its online learning platform offering free continuing education (CE) credits to veterinary professionals. ElleVet Academy courses aim to empower veterinary professionals with the knowledge and skills needed to confidently incorporate cannabinoid-based products into their practice to support patients with osteoarthritis, epilepsy, atopic dermatitis, and anxiety.

ElleVet Academy's curriculum is designed by accomplished veterinary professionals who have played significant roles in defining cannabinoid use through groundbreaking research and clinical trials. "ElleVet Academy represents a pivotal step in advancing veterinary education," said Dr. Joseph J. Wakshlag, Chief Veterinary Medical Officer, ElleVet Sciences. "By providing free, science-based continuing education courses on cannabinoid science, we empower veterinary professionals to enhance the quality of their patients' lives through the use of cannabinoids."

Key Highlights of ElleVet Academy:

"Research has consistently driven ElleVet's mission," said Christian Kjaer, CEO and Co-Founder of ElleVet Sciences. "The launch of ElleVet Academy represents an important step in providing the tools veterinary professionals need to benefit from the scientific breakthroughs ElleVet and leading research institutes have achieved in the area of cannabinoid use with cats, dogs, and other species."

About ElleVet Academy

ElleVet Academy was founded with a passion to share cannabinoid veterinary science directly with veterinary professionals seeking to provide a better quality of life for their patients. The academy's free, CE courses approved by RACE are rooted in the latest cannabinoid research, and its team of accomplished veterinary professionals and scientists is dedicated to advancing the understanding and application of cannabinoids in veterinary medicine. For more information about ElleVet Academy and to enroll in free courses, visit https://www.ElleVetAcademy.com.

About ElleVet Sciences

ElleVet Sciences is a leading science-focused pet CBD + CBDA company based in Portland, Maine, USA. As the first and only organization to conduct successful CBD + CBDA clinical trials, ElleVet has pioneered the use of complete spectrum cannabinoid oil to support mobility, stress, skin, neuro, and cognitive health in pets. ElleVet's team includes the very same veterinary professionals who brought CBD + CBDA veterinary science to the forefront of pet health research. ElleVet was founded in 2017, the same year their landmark clinical trial on osteoarthritis was completed at Cornell University College of Veterinary Medicine. With more than 40 clinical trials and R&D projects completed or underway, ElleVet Sciences is committed to improving the lives of pets through science and innovation.

For more information please visit ellevetsciences.com or on social media at @Ellevetsciences on Facebook and Instagram.

Media Contact

Bob Menardi, DVM, ElleVet Sciences, 678-343-3402, [email protected]https://www.ellevetsciences.com/ 

SOURCE ElleVet Sciences


These press releases may also interest you

at 05:30
Provisio Medical, Inc. today announced the formation of a Physician Advisory Board (PAB) comprising a multidisciplinary group of physicians who will provide input and feedback on product development decisions, outcome- focused clinical studies and...

at 05:00
Boehringer Ingelheim today presented positive data from the HORNBILL Phase I/IIa study of BI 764524, the first ever study exploring a potential treatment for people living with diabetic macular ischemia (DMI). The study found that BI 764524 was well...

at 04:21
The revenue in April for Zinzino's sales markets increased by 34 % and amounted to SEK 155.7 (116.0) million. Faun Pharma's external sales increased by 54 % and amounted to SEK 8.0 (5.2) million. Overall, the Group increased revenues by 35 % to SEK...

at 04:00
Nearly all American adults (95%) agree stroke is an emergency, yet according to new omnibus survey by The Harris Poll on behalf of the Get Ahead of Stroke® campaign, less than half (43%) say they would call 911 if they were experiencing a common...

at 04:00
Pan-Canadian children's health advocate Children's Healthcare Canada is calling on the federal government to show political will to solve the crises plaguing children's healthcare and declare children's health and well-being a national priority. ...

at 03:44
21st.BIO unveiled a new pilot plant facility in its Danish...



News published on and distributed by: